Genetic variation in dopamine pathways differentially associated with smoking progression in adolescence

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 47, Issue 6, 2008, Pages 673-681

  Laucht, Manfred ^a,d   Becker, Katja ^a   Frank, Josef ^a   Schmidt, Martin H ^a   Esser, Günter ^b   Treutlein, Jens ^a   Skowronek, Markus H ^a   Schumann, Gunter ^c  

^a Central Institute of Mental Health   (Germany)

^b UNIVERSITY OF POTSDAM   (Germany)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

Adolescence; Dopamine; Genetics; Polymorphism; Smoking

Indexed keywords

DOPAMINE; DOPAMINE 4 RECEPTOR; DOPAMINE TRANSPORTER; DOPAMINE 2 RECEPTOR;

ADOLESCENCE; ADOLESCENT; ARTICLE; DISEASE COURSE; DOPAMINERGIC SYSTEM; FEMALE; GENETIC RISK; GENETIC VARIABILITY; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TOBACCO DEPENDENCE; VARIABLE NUMBER OF TANDEM REPEAT; 3' UNTRANSLATED REGION; ALLELE; BRAIN; GENETICS; GERMANY; HETEROZYGOTE DETECTION; HOMOZYGOTE; NUCLEOTIDE REPEAT; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; RISK FACTOR; SMOKING CESSATION;

3' UNTRANSLATED REGIONS; ADOLESCENT; ALLELES; BRAIN; DISEASE PROGRESSION; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GERMANY; HETEROZYGOTE DETECTION; HOMOZYGOTE; HUMANS; LONGITUDINAL STUDIES; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4; REPETITIVE SEQUENCES, NUCLEIC ACID; RISK FACTORS; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER; VARIATION (GENETICS);

EID: 44849114019     PISSN: 08908567     EISSN: 15275418     Source Type: Journal    
DOI: 10.1097/CHI.0b013e31816bff77     Document Type: Article

References (47)

1. Leonard S, Bertrand D. Neuronal nicotinic receptors: from structure to fonction. Nicotine Tob Res. 2001;3:205-223.
2. Batra V, Patkar AA, Berrettini WH, Weinstein SP, Leone FT. The genetic determinants of smoking. Chest. 2003;123:1730-1739.
3. Munafo M, Clark T, Johnstone E, Murphy M, Walton R. The genetic basis for smoking behavior: a systematic review and meta-analysis. Nicotine Tob Res. 2004;6:583-597.
4. Li MD. The genetics of nicotine dependence. Curr Psychiatry Rep. 2006;8:158-164.
5. Shippenberg TS, Herz A, Spanagel R, Bals-Kubik R, Stein C. Conditioning of opioid reinforcement: neuroanatomical and neurochemical substrates. Ann N Y Acad Sci. 1992;654:347-356.
6. Nestler EJ. From neurobiology to treatment: progress against addiction. Nat Neurosci. 2002;5(Suppl 1):1076-1079.
7. Thompson J, Thomas N, Singleton A, et al. D2 dopamine receptor gene (DRD2) Taq 1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics. 1997;7:479-484.
8. Neville MJ, Johnstone EC, Walton RT. Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum Mutat. 2004;23:540-545.
9. Fossella J, Green AE, Fan J. Evaluation of a structural polymorphism in the ankyrin repeat and kinase domain containing 1 (ANKK1) gene and the activation of executive attention networks. Cogn Affect Behav Neurosci. 2006;6:71-78.
10. Goldstein RZ, Volkow ND. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry. 2002;159:1642-1652.
11. Noble EP, St Jeor ST, Ritchie T, et al. D2 dopamine receptor gene and cigarette smoking: a reward gene? Med Hypotheses. 1994;42:257-260.
12. Comings DE, Ferry L, Bradshaw-Robinson S, Burchette R, Chiu C, Muhleman D. The dopamine D2 receptor (DRD2) gene: a genetic risk factor in smoking. Pharmacogenetics. 1996;6:73-79.
13. Batra A, Gelfort G, Barrels M, et al. The dopamine D2 receptor (DRD2) gene - a genetic risk (actor in heavy smoking? Addict Biol. 2000;5:429-436.
14. Singleton AB, Thomson JH, Morris CM, Court JA, Lloyd S, Cholerton S. Lack of association between the dopamine D2 receptor gene allele DRD2*A1 and cigarette smoking in a United Kingdom population. Pharmacogenetics. 1998;8:125-128.
15. Li MD, Ma JZ, Beuten J. Progress in searching for susceptibility loci and genes for smoking-related behaviour. Clin Genet. 2004;66:382-392.
16. Le Foll B, Goldberg SR, Sokoloff P. The dopamine D3 receptor and drug dependence: effects on reward or beyond? Neurophannacology. 2005;49:525-541.
17. Crocq M, Duval F, Mayerova A, Sokoloff P, Mokrani M, Macher JP. Clinical and functional correlates of a dopamine D3 receptor polymorphism. Hum Psychopharmacol. 1995;10:19-24.
18. Lichter JB, Barr CL, Kennedy JL, Van Tol HH, Kidd KK, Livak KJ. A hypervariable segment in the human dopamine receptor D4 (DRD4) gene. Hum Mol Genet. 1993;2:767-773.
19. Oak JN, Oidenhof J, Van Tol HH. The dopamine D(4) receptor: one decade of research. Eur J Pharmacol. 2000;405:303-327.
20. Wong AH, Van Tol HH. The dopamine D4 receptors and mechanisms of antipsychotic atypicality. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27:1091-1099.
21. Shields PG, Lerman C, Audrain J, et al. Dopamine D4 receptors and the risk of cigarette smoking in African-Americans and Caucasians. Cancer EpidemiolBiomarkers Prev. 1998;7:453-458.
22. Laucht M, Becker K, El Faddagh M, Hohm E, Schmidt MH. Association of the DRD4 exon III polymorphism with smoking in fifteen-year-olds: a mediating role for novelty seeking? J Am Acad Child Adolesc Psychiatry. 2005;44:477-484.
23. Kang AM, Palmatier MA, Kidd KK. Global variation of a 40-bp VNTR in the 3-untranslated region of the dopamine transporter gene (SLC6A3). Biol Psychiatry. 1999;46:151-160.
24. Heinz A, Goldman D, Jones DW, et al. Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology. 2000;22:133-139.
25. Jacobsen LK, Staley JK, Zoghbi SS, et al. Prediction of dopamine transporter binding availability by genotype: a preliminary report. Am J Psychiatry. 2000;157:1700-1703.
26. Lerman C, Caporaso NE, Audrain J, et al. Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychol. 1999;18:14-20.
27. Vandenbergh DJ, Bennett CJ, Grant MD, et al. Smoking status and the human dopamine transporter variable number of tandem repeats (VNTR) polymorphism: failure to replicate and finding that never-smokers may be different. Nicotine Tob Res. 2002;4:333-340.
28. Mayhew KP, Flay BR, Mott JA. Stages in the development of adolescent smoking. Drug Alcohol Depend. 2000;59(Suppl 1):S61-S81.
29. Heath AC, Martin NG. Genetic models for the natural history of smoking: evidence fora genetic influence on smoking persistence. Addict Behav. 1993;18:19-34.
30. Heath AC, Kirk KM, Meyer JM, Martin NG. Genetic and social determinants of initiation and age at onset of smoking in Australian twins. Behav Genet. 1999;29:395-407.
31. Kendler KS, Neale MC, Sullivan P, Corey LA, Gardner CO, Prescott CA. A population-based twin study in women of smoking initiation and nicotine dependence. Psychol Med. 1999;29:299-308.
32. Reiss D, Neiderhiser JM. The interplay of genetic influences and social processes in developmental theory: specific mechanisms are coming into view. Dev Psychopathol. 2000;12:357-374.
33. Audrain-McGovern J, Lerman C, Wileyto EP, Rodriguez D, Shields PG. Interacting effects of genetic predisposition and depression on adolescent smoking progression. Am J Psychiatry. 2004;161:1224-1230.
34. Laucht M, Esser G, Baving L, et al. Behavioral sequelae of perinatal insults and early family adversity at 8 years of age. J Am Acad Child Adolesc Psychiatry. 2000;39:1229-1237.
35. Laucht M, Esser G, Schmidt MH. Developmental outcome of infants born with biological and psychosocial risks, J Child Psychol Psychiatry. 1997;38:843-853.
36. Müller R, Abbet JP. [Changing Trends in the Consumption of Legal and Illegal Drugs by 11-16-Year-Old Adolescent Pupils. Findings from a Study Conducted Under the Auspices of the WHO Europe]. Lausanne: Swiss Professional Service for Alcohol Problems; 1991.
37. Fagerstrom KO, Schneider NG. Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J Behav Med. 1989;12:159-182.
38. Grandy DK, Zhang Y, Civelli O. PCR detection of the TaqA RFLP at the DRD2 locus. Hum Mol Genet. 1993;2:2197.
39. Sano A, Kondoh K, Kakimoto Y, Kondo I. A 40-nucleotide repeat polymorphism in the human dopamine transporter gene. Hum Genet. 1993;91:405-406.
40. Chang FM, Kidd JR, Livak KJ, Pakstis AJ, Kidd KK. The world-wide distribution of allele frequencies at the human dopamine D4 receptor locus. Hum Genet. 1996;98:91-101.
41. Noble EP. D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. Am J Med Genet B Neuropsychiatr Genet. 2003;116B:103-125.
42. Schumann G, Benedetti F, Voderholzer U, et al. Antidepressive response to sleep deprivation in unipolar depression is not associated with dopamine D3 receptor genotype. Neuropsychohiohgy. 2001;43:127-130.
43. Kluger AN, Siegfried Z, Ebstein RP. A meta-analysis of the association between DRD4 polymorphism and novelty seeking. Mol Psychiatry. 2002;7:712-717.
44. Cloninger CR, Svrakic DM, Przybeck TR. A psychobiological model of temperament and character. Arch Gen Psychiatry. 1993;50:975-990.
45. Noble EP, Blum K, Ritchie T, Montgomery A, Sheridan PJ. Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry. 1991;48:648-654.
46. Hutchison KE, Stallings M, McGeary J, Bryan A. Population stratification in the candidate gene study: fatal threat or red herring? Psychol Bull. 2004;130:66-79.
47. Audrain-McGovern J, Rodriguez D, Wileyto EP, Schmitz KH, Shields PG. Effect of team sport participation on genetic predisposition to adolescent smoking progression. Arch Gen Psychiatry. 2006;63:433-441.